I started my scientific career deeply engaged with drug discovery and with the development of innovative synthetic strategies and procedures to obtain concise and diverse-orientated chemical libraries based on natural products. The obtained libraries were screened toward several biological targets to develop enzymatic inhibitors and ligands of adenosine receptors aiming the discovery and development of new drug candidates to address multifactorial diseases such as cancer and neurodegenerative diseases. In addition, when required, I have performed the antioxidant evaluation of diverse system. Over the years I have been genuinely engaged in acquiring and developing a vast number of skills in the field of medicinal chemistry, allowing me to be aware of the importance of its transdisciplinary research and of the tools that are involved in the daily routine of the multidisciplinary R&D projects and of the overall process inherent to drug discovery and development. Currently, My research is focused on the design and development of new antimicrobial drugs based on naturally-occurring privileged structures. In this context, I collaborate with LEPABE in the group of Prof. Manuel Simões, to improve my skills in the area, and I establish an international collaboration with CO-ADD (Community for Open Antimicrobial Drug Discovery). At present more than 50 compounds were screened against several antibacterial and antifungal strains.